Skip to content

Effect of Timi3 Ultrasound on Myocardial Blow Flow in the Hibernating Myocardium

Evaluation of the Effect of T3US on Myocardial Blow Flow in the Hibernating

Status
Terminated
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00655070
Enrollment
9
Registered
2008-04-09
Start date
2008-04-30
Completion date
2010-12-31
Last updated
2012-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Ischemia

Keywords

Hibernating Myocardium, Blood Flow, Ultrasound, PET imaging

Brief summary

The purpose of this study is to evaluate whether the use application of low frequency ultrasound, administered by the Timi3 ultrasound device, increases myocardial blood flow to the heart, in subjects with reduced myocardial blood flow at rest (hibernating myocardium). The primary endpoint of the trial is to assess the increase in myocardial blood flow from baseline to post Timi3 Ultrasound treatment in a hypoperfused region of myocardium. Positron emission tomography (PET) imaging will be used to noninvasively evaluate cardiac blood flow. The hypothesis is that ultrasound increases blood flow in hibernating myocardium.

Interventions

DEVICETimi3 Transthoracic ultrasound

Low frequency ultrasound over the chest using Timi3 ultrasound device

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \>/= 18 years * Must have reversible resting ischemia, resting non-reversible blood flow defect, or stress-induced ischemia. * Females with childbearing potential must not be pregnant at the time of the study * Must provide written informed consent

Exclusion criteria

* Unable or unwilling to cooperate with study procedures * Currently enrolled in another clinical study for which the follow-up period is not complete

Design outcomes

Primary

MeasureTime frame
Change in myocardial blood flow from baseline to post ultrasound treatmentimmediate post treatment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026